Loading…
Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug
Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitro...
Saved in:
Published in: | European journal of medicinal chemistry 2012-12, Vol.58, p.214-227 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c392t-68dd69c6299545d5b1caf0fba585cd2d162e8884204be21256ce5821e8f054a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c392t-68dd69c6299545d5b1caf0fba585cd2d162e8884204be21256ce5821e8f054a3 |
container_end_page | 227 |
container_issue | |
container_start_page | 214 |
container_title | European journal of medicinal chemistry |
container_volume | 58 |
creator | Vega, María Celeste Rolón, Miriam Montero-Torres, Alina Fonseca-Berzal, Cristina Escario, José Antonio Gómez-Barrio, Alicia Gálvez, Jorge Marrero-Ponce, Yovani Arán, Vicente J. |
description | Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitroindazolin-3-ones (21, 33) and in order to initiate the optimization of activity of this kind of compounds, we have prepared a series of related analogs (22–32, 34–38, 58 and 59) and tested in vitro these products against epimastigote forms of Trypanosoma cruzi. 2-Benzyl-1-propyl (22), 2-benzyl-1-isopropyl (23) and 2-benzyl-1-butyl (24) derivatives have shown high trypanocidal activity and low unspecific toxicity. Other indazole derivatives with different substitution patterns (1-substituted 3-alkoxy-1H-indazoles and 2-substituted 3-alkoxy-2H-indazoles), arising from the synthetic procedures used to prepare the mentioned indazolinones, have moderate to low effectiveness. The exploration of SAR information using the concept of an activity landscape has been carried out with SARANEA software. We have also searched for structural similarities between 225 known antiprotozoan drugs and compound 22. The results confirm that compounds 22–24 constitute promising leads and that 5-nitroindazolin-3-one system is a novel anti-T. cruzi scaffold which may represent an important therapeutic alternative for the treatment of Chagas disease.
[Display omitted]
► 1,2-Disubstituted 5-nitroindazolin-3-ones constitute a new and promising trypanocidal scaffold. ► 1-Alkyl-2-benzyl derivatives are very active against Trypanosoma cruzi epimastigotes (IC50 ca. 1–2 μM). ► Best 1,2-disubstituted indazolinones show low unspecific cytotoxicity and their preparation is very simple. |
doi_str_mv | 10.1016/j.ejmech.2012.10.009 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1221852850</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523412006125</els_id><sourcerecordid>1221852850</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-68dd69c6299545d5b1caf0fba585cd2d162e8884204be21256ce5821e8f054a3</originalsourceid><addsrcrecordid>eNp9kcGO0zAQhiMEYrsLb4CQL0gcNsGexF7ngoQWFpBW4sDeLceetK4Su9hOUXkYnhWXFrhxsjz6Zv7RfFX1gtGGUSbebBvczmg2DVAGpdRQ2j-qVuxGyLoF3j2uVhSgrTm03UV1mdKWUsoFpU-rC2gZdMDkqvr59eDzBpNL12RwYQprZ_REcK-nRWcXPNHeErPBOcyYozPlr6dD4UkYifNW_wgTEovR7Qu_x9QQdg31e5eWIWWXl4yW8Nq7HMMZdz54LHkev5NdDDnkww5_z9M-O7PRa51KkI3L-ln1ZNRTwufn96p6uPvwcPupvv_y8fPtu_vatD3kWkhrRW8E9D3vuOUDM3qk46C55MaCZQJQStkB7QYEBlwY5BIYypHyTrdX1evT2LLOtwVTVrNLBqdJewxLUgzKsThITgvanVATQ0oRR7WLbtbxoBhVRzFqq05i1FHMsVrElLaX54RlmNH-bfpjogCvzoBOxcAYtTcu_ePEjWA97Qr39sRhOcfeYVTJOPQGrYtosrLB_X-TX5TtsQU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1221852850</pqid></control><display><type>article</type><title>Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug</title><source>ScienceDirect Freedom Collection</source><creator>Vega, María Celeste ; Rolón, Miriam ; Montero-Torres, Alina ; Fonseca-Berzal, Cristina ; Escario, José Antonio ; Gómez-Barrio, Alicia ; Gálvez, Jorge ; Marrero-Ponce, Yovani ; Arán, Vicente J.</creator><creatorcontrib>Vega, María Celeste ; Rolón, Miriam ; Montero-Torres, Alina ; Fonseca-Berzal, Cristina ; Escario, José Antonio ; Gómez-Barrio, Alicia ; Gálvez, Jorge ; Marrero-Ponce, Yovani ; Arán, Vicente J.</creatorcontrib><description>Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitroindazolin-3-ones (21, 33) and in order to initiate the optimization of activity of this kind of compounds, we have prepared a series of related analogs (22–32, 34–38, 58 and 59) and tested in vitro these products against epimastigote forms of Trypanosoma cruzi. 2-Benzyl-1-propyl (22), 2-benzyl-1-isopropyl (23) and 2-benzyl-1-butyl (24) derivatives have shown high trypanocidal activity and low unspecific toxicity. Other indazole derivatives with different substitution patterns (1-substituted 3-alkoxy-1H-indazoles and 2-substituted 3-alkoxy-2H-indazoles), arising from the synthetic procedures used to prepare the mentioned indazolinones, have moderate to low effectiveness. The exploration of SAR information using the concept of an activity landscape has been carried out with SARANEA software. We have also searched for structural similarities between 225 known antiprotozoan drugs and compound 22. The results confirm that compounds 22–24 constitute promising leads and that 5-nitroindazolin-3-one system is a novel anti-T. cruzi scaffold which may represent an important therapeutic alternative for the treatment of Chagas disease.
[Display omitted]
► 1,2-Disubstituted 5-nitroindazolin-3-ones constitute a new and promising trypanocidal scaffold. ► 1-Alkyl-2-benzyl derivatives are very active against Trypanosoma cruzi epimastigotes (IC50 ca. 1–2 μM). ► Best 1,2-disubstituted indazolinones show low unspecific cytotoxicity and their preparation is very simple.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2012.10.009</identifier><identifier>PMID: 23124218</identifier><identifier>CODEN: EJMCA5</identifier><language>eng</language><publisher>Kidlington: Elsevier Masson SAS</publisher><subject>Antiprotozoan agents ; Biological and medical sciences ; Chagas disease ; Cluster analysis ; Cytotoxicity ; Dose-Response Relationship, Drug ; Indazoles ; Indazoles - chemical synthesis ; Indazoles - chemistry ; Indazoles - pharmacology ; Medical sciences ; Miscellaneous ; Models, Molecular ; Molecular Structure ; Parasitic Sensitivity Tests ; Pharmacology. Drug treatments ; Structure-Activity Relationship ; Structure–activity relationships ; Trypanocidal Agents - chemical synthesis ; Trypanocidal Agents - chemistry ; Trypanocidal Agents - pharmacology ; Trypanosoma cruzi - drug effects</subject><ispartof>European journal of medicinal chemistry, 2012-12, Vol.58, p.214-227</ispartof><rights>2012 Elsevier Masson SAS</rights><rights>2014 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-68dd69c6299545d5b1caf0fba585cd2d162e8884204be21256ce5821e8f054a3</citedby><cites>FETCH-LOGICAL-c392t-68dd69c6299545d5b1caf0fba585cd2d162e8884204be21256ce5821e8f054a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26761904$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23124218$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vega, María Celeste</creatorcontrib><creatorcontrib>Rolón, Miriam</creatorcontrib><creatorcontrib>Montero-Torres, Alina</creatorcontrib><creatorcontrib>Fonseca-Berzal, Cristina</creatorcontrib><creatorcontrib>Escario, José Antonio</creatorcontrib><creatorcontrib>Gómez-Barrio, Alicia</creatorcontrib><creatorcontrib>Gálvez, Jorge</creatorcontrib><creatorcontrib>Marrero-Ponce, Yovani</creatorcontrib><creatorcontrib>Arán, Vicente J.</creatorcontrib><title>Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitroindazolin-3-ones (21, 33) and in order to initiate the optimization of activity of this kind of compounds, we have prepared a series of related analogs (22–32, 34–38, 58 and 59) and tested in vitro these products against epimastigote forms of Trypanosoma cruzi. 2-Benzyl-1-propyl (22), 2-benzyl-1-isopropyl (23) and 2-benzyl-1-butyl (24) derivatives have shown high trypanocidal activity and low unspecific toxicity. Other indazole derivatives with different substitution patterns (1-substituted 3-alkoxy-1H-indazoles and 2-substituted 3-alkoxy-2H-indazoles), arising from the synthetic procedures used to prepare the mentioned indazolinones, have moderate to low effectiveness. The exploration of SAR information using the concept of an activity landscape has been carried out with SARANEA software. We have also searched for structural similarities between 225 known antiprotozoan drugs and compound 22. The results confirm that compounds 22–24 constitute promising leads and that 5-nitroindazolin-3-one system is a novel anti-T. cruzi scaffold which may represent an important therapeutic alternative for the treatment of Chagas disease.
[Display omitted]
► 1,2-Disubstituted 5-nitroindazolin-3-ones constitute a new and promising trypanocidal scaffold. ► 1-Alkyl-2-benzyl derivatives are very active against Trypanosoma cruzi epimastigotes (IC50 ca. 1–2 μM). ► Best 1,2-disubstituted indazolinones show low unspecific cytotoxicity and their preparation is very simple.</description><subject>Antiprotozoan agents</subject><subject>Biological and medical sciences</subject><subject>Chagas disease</subject><subject>Cluster analysis</subject><subject>Cytotoxicity</subject><subject>Dose-Response Relationship, Drug</subject><subject>Indazoles</subject><subject>Indazoles - chemical synthesis</subject><subject>Indazoles - chemistry</subject><subject>Indazoles - pharmacology</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>Parasitic Sensitivity Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Structure-Activity Relationship</subject><subject>Structure–activity relationships</subject><subject>Trypanocidal Agents - chemical synthesis</subject><subject>Trypanocidal Agents - chemistry</subject><subject>Trypanocidal Agents - pharmacology</subject><subject>Trypanosoma cruzi - drug effects</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kcGO0zAQhiMEYrsLb4CQL0gcNsGexF7ngoQWFpBW4sDeLceetK4Su9hOUXkYnhWXFrhxsjz6Zv7RfFX1gtGGUSbebBvczmg2DVAGpdRQ2j-qVuxGyLoF3j2uVhSgrTm03UV1mdKWUsoFpU-rC2gZdMDkqvr59eDzBpNL12RwYQprZ_REcK-nRWcXPNHeErPBOcyYozPlr6dD4UkYifNW_wgTEovR7Qu_x9QQdg31e5eWIWWXl4yW8Nq7HMMZdz54LHkev5NdDDnkww5_z9M-O7PRa51KkI3L-ln1ZNRTwufn96p6uPvwcPupvv_y8fPtu_vatD3kWkhrRW8E9D3vuOUDM3qk46C55MaCZQJQStkB7QYEBlwY5BIYypHyTrdX1evT2LLOtwVTVrNLBqdJewxLUgzKsThITgvanVATQ0oRR7WLbtbxoBhVRzFqq05i1FHMsVrElLaX54RlmNH-bfpjogCvzoBOxcAYtTcu_ePEjWA97Qr39sRhOcfeYVTJOPQGrYtosrLB_X-TX5TtsQU</recordid><startdate>20121201</startdate><enddate>20121201</enddate><creator>Vega, María Celeste</creator><creator>Rolón, Miriam</creator><creator>Montero-Torres, Alina</creator><creator>Fonseca-Berzal, Cristina</creator><creator>Escario, José Antonio</creator><creator>Gómez-Barrio, Alicia</creator><creator>Gálvez, Jorge</creator><creator>Marrero-Ponce, Yovani</creator><creator>Arán, Vicente J.</creator><general>Elsevier Masson SAS</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121201</creationdate><title>Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug</title><author>Vega, María Celeste ; Rolón, Miriam ; Montero-Torres, Alina ; Fonseca-Berzal, Cristina ; Escario, José Antonio ; Gómez-Barrio, Alicia ; Gálvez, Jorge ; Marrero-Ponce, Yovani ; Arán, Vicente J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-68dd69c6299545d5b1caf0fba585cd2d162e8884204be21256ce5821e8f054a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antiprotozoan agents</topic><topic>Biological and medical sciences</topic><topic>Chagas disease</topic><topic>Cluster analysis</topic><topic>Cytotoxicity</topic><topic>Dose-Response Relationship, Drug</topic><topic>Indazoles</topic><topic>Indazoles - chemical synthesis</topic><topic>Indazoles - chemistry</topic><topic>Indazoles - pharmacology</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>Parasitic Sensitivity Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Structure-Activity Relationship</topic><topic>Structure–activity relationships</topic><topic>Trypanocidal Agents - chemical synthesis</topic><topic>Trypanocidal Agents - chemistry</topic><topic>Trypanocidal Agents - pharmacology</topic><topic>Trypanosoma cruzi - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vega, María Celeste</creatorcontrib><creatorcontrib>Rolón, Miriam</creatorcontrib><creatorcontrib>Montero-Torres, Alina</creatorcontrib><creatorcontrib>Fonseca-Berzal, Cristina</creatorcontrib><creatorcontrib>Escario, José Antonio</creatorcontrib><creatorcontrib>Gómez-Barrio, Alicia</creatorcontrib><creatorcontrib>Gálvez, Jorge</creatorcontrib><creatorcontrib>Marrero-Ponce, Yovani</creatorcontrib><creatorcontrib>Arán, Vicente J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vega, María Celeste</au><au>Rolón, Miriam</au><au>Montero-Torres, Alina</au><au>Fonseca-Berzal, Cristina</au><au>Escario, José Antonio</au><au>Gómez-Barrio, Alicia</au><au>Gálvez, Jorge</au><au>Marrero-Ponce, Yovani</au><au>Arán, Vicente J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2012-12-01</date><risdate>2012</risdate><volume>58</volume><spage>214</spage><epage>227</epage><pages>214-227</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><coden>EJMCA5</coden><abstract>Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitroindazolin-3-ones (21, 33) and in order to initiate the optimization of activity of this kind of compounds, we have prepared a series of related analogs (22–32, 34–38, 58 and 59) and tested in vitro these products against epimastigote forms of Trypanosoma cruzi. 2-Benzyl-1-propyl (22), 2-benzyl-1-isopropyl (23) and 2-benzyl-1-butyl (24) derivatives have shown high trypanocidal activity and low unspecific toxicity. Other indazole derivatives with different substitution patterns (1-substituted 3-alkoxy-1H-indazoles and 2-substituted 3-alkoxy-2H-indazoles), arising from the synthetic procedures used to prepare the mentioned indazolinones, have moderate to low effectiveness. The exploration of SAR information using the concept of an activity landscape has been carried out with SARANEA software. We have also searched for structural similarities between 225 known antiprotozoan drugs and compound 22. The results confirm that compounds 22–24 constitute promising leads and that 5-nitroindazolin-3-one system is a novel anti-T. cruzi scaffold which may represent an important therapeutic alternative for the treatment of Chagas disease.
[Display omitted]
► 1,2-Disubstituted 5-nitroindazolin-3-ones constitute a new and promising trypanocidal scaffold. ► 1-Alkyl-2-benzyl derivatives are very active against Trypanosoma cruzi epimastigotes (IC50 ca. 1–2 μM). ► Best 1,2-disubstituted indazolinones show low unspecific cytotoxicity and their preparation is very simple.</abstract><cop>Kidlington</cop><pub>Elsevier Masson SAS</pub><pmid>23124218</pmid><doi>10.1016/j.ejmech.2012.10.009</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0223-5234 |
ispartof | European journal of medicinal chemistry, 2012-12, Vol.58, p.214-227 |
issn | 0223-5234 1768-3254 |
language | eng |
recordid | cdi_proquest_miscellaneous_1221852850 |
source | ScienceDirect Freedom Collection |
subjects | Antiprotozoan agents Biological and medical sciences Chagas disease Cluster analysis Cytotoxicity Dose-Response Relationship, Drug Indazoles Indazoles - chemical synthesis Indazoles - chemistry Indazoles - pharmacology Medical sciences Miscellaneous Models, Molecular Molecular Structure Parasitic Sensitivity Tests Pharmacology. Drug treatments Structure-Activity Relationship Structure–activity relationships Trypanocidal Agents - chemical synthesis Trypanocidal Agents - chemistry Trypanocidal Agents - pharmacology Trypanosoma cruzi - drug effects |
title | Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A05%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis,%20biological%20evaluation%20and%20chemometric%20analysis%20of%20indazole%20derivatives.%201,2-Disubstituted%205-nitroindazolinones,%20new%20prototypes%20of%20antichagasic%20drug&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Vega,%20Mar%C3%ADa%20Celeste&rft.date=2012-12-01&rft.volume=58&rft.spage=214&rft.epage=227&rft.pages=214-227&rft.issn=0223-5234&rft.eissn=1768-3254&rft.coden=EJMCA5&rft_id=info:doi/10.1016/j.ejmech.2012.10.009&rft_dat=%3Cproquest_cross%3E1221852850%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c392t-68dd69c6299545d5b1caf0fba585cd2d162e8884204be21256ce5821e8f054a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1221852850&rft_id=info:pmid/23124218&rfr_iscdi=true |